WallStreetZenWallStreetZen

NASDAQ: TYRA
Tyra Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for TYRA

Based on 2 analysts offering 12 month price targets for Tyra Biosciences Inc.
Min Forecast
$23.00+41.1%
Avg Forecast
$25.50+56.44%
Max Forecast
$28.00+71.78%

Should I buy or sell TYRA stock?

Based on 2 analysts offering ratings for Tyra Biosciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TYRA stock forecasts and price targets.

TYRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-03-20

1 of 1

Forecast return on equity

Is TYRA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is TYRA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TYRA revenue forecast

What is TYRA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.6M
Avg 2 year Forecast
$77.4M
Avg 3 year Forecast
$257.1M

TYRA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TYRA$16.30$25.50+56.44%Buy
SLN$21.82$57.25+162.37%Strong Buy
NUVB$3.97$6.25+57.43%Strong Buy
PLRX$14.55$46.67+220.74%Buy
CRGX$22.41$29.67+32.38%Strong Buy

Tyra Biosciences Stock Forecast FAQ

Is Tyra Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TYRA) stock is to Buy TYRA stock.

Out of 2 analysts, 0 (0%) are recommending TYRA as a Strong Buy, 2 (100%) are recommending TYRA as a Buy, 0 (0%) are recommending TYRA as a Hold, 0 (0%) are recommending TYRA as a Sell, and 0 (0%) are recommending TYRA as a Strong Sell.

If you're new to stock investing, here's how to buy Tyra Biosciences stock.

What is TYRA's revenue growth forecast for 2026-2028?

(NASDAQ: TYRA) Tyra Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Tyra Biosciences's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast TYRA's revenue for 2026 to be $554,622,288, with the lowest TYRA revenue forecast at $554,622,288, and the highest TYRA revenue forecast at $554,622,288. On average, 3 Wall Street analysts forecast TYRA's revenue for 2027 to be $4,062,818,344, with the lowest TYRA revenue forecast at $2,766,283,704, and the highest TYRA revenue forecast at $4,971,117,383.

In 2028, TYRA is forecast to generate $13,504,369,939 in revenue, with the lowest revenue forecast at $10,480,575,528 and the highest revenue forecast at $19,526,275,969.

What is TYRA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TYRA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TYRA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TYRA price target, the average TYRA price target is $25.50, with the highest TYRA stock price forecast at $28.00 and the lowest TYRA stock price forecast at $23.00.

On average, Wall Street analysts predict that Tyra Biosciences's share price could reach $25.50 by Mar 21, 2025. The average Tyra Biosciences stock price prediction forecasts a potential upside of 56.44% from the current TYRA share price of $16.30.

What is TYRA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TYRA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.